SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Former director Saira Ramasastry filed a Form 144 on June 29, 2026,…

Vir Biotechnology, Inc. · 144 filed Jun 29, 2026 at 15:06 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 29, 2026 at 15:06 ET

Former director Saira Ramasastry filed a Form 144 on June 29, 2026, indicating intent to sell 16,000 shares of Vir Biotechnology (VIR) with an approximate market value of $165,139. The sale follows a stock option exercise and represents a routine diversification move by a former board member, not a current executive. Given the small size relative to VIR's $1.7B market cap and the insider's former-director status, the signal is minimal.

  • Insider: Saira Ramasastry, former director
  • Shares to be sold: 16,000 shares of common stock
  • Estimated value: ~$165,139
  • Source of shares: stock option exercise (issuer grant)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access